97 related articles for article (PubMed ID: 2561546)
21. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
Seo JH; Park BC
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
[TBL] [Abstract][Full Text] [Related]
22. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
[TBL] [Abstract][Full Text] [Related]
23. Clinical expression of HDV infection: presentation of illustrative cases.
Hadziyannis SJ; Sherlock DS
Prog Clin Biol Res; 1993; 382():295-300. PubMed ID: 8389051
[No Abstract] [Full Text] [Related]
24. Molecular pathophysiology of persistent hepatitis B virus infection in relation to chronic liver disease and primary hepatocellular carcinoma.
Shafritz DA; Hadziyannis SJ
Monogr Pathol; 1987; (28):136-52. PubMed ID: 3023975
[No Abstract] [Full Text] [Related]
25. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
26. e-antigen-negative chronic hepatitis B in Bangladesh.
Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus.
Roudot-Thoraval F; Bastie A; Pawlotsky JM; Dhumeaux D
Hepatology; 1997 Aug; 26(2):485-90. PubMed ID: 9252163
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
29. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
[TBL] [Abstract][Full Text] [Related]
30. Relationship of hepatocellular carcinoma, liver cirrhosis, and hepatitis B virus. A pathologic study of 1,069 autopsy cases in different areas of China.
Ying YY; Yan RQ; Xu BD; Wang LX; Wang YL; Qian YL
Chin Med J (Engl); 1984 Oct; 97(10):758-64. PubMed ID: 6100440
[No Abstract] [Full Text] [Related]
31. [Relationship between hepatocellular carcinoma, liver cirrhosis and hepatitis B: a pathological study].
Zhonghua Yi Xue Za Zhi; 1982 May; 62(5):257-61. PubMed ID: 6290005
[No Abstract] [Full Text] [Related]
32. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
[TBL] [Abstract][Full Text] [Related]
33. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
[TBL] [Abstract][Full Text] [Related]
34. Natural course of chronic hepatitis C.
Takahashi M; Yamada G; Miyamoto R; Doi T; Endo H; Tsuji T
Am J Gastroenterol; 1993 Feb; 88(2):240-3. PubMed ID: 8424428
[TBL] [Abstract][Full Text] [Related]
35. Primary hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kiszkis H
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):315-23. PubMed ID: 9017146
[TBL] [Abstract][Full Text] [Related]
36. Chronic hepatitis; prognostic aspects.
Fehér J; Jakab L; Süle I; Szilvási I; Józsa L
Acta Med Acad Sci Hung; 1976; 33(4):299-307. PubMed ID: 1032237
[TBL] [Abstract][Full Text] [Related]
37. [Incidence of anti-HCV positivity in a Sicilian population with liver diseases].
Montalto G; Soresi M; Tripi S; Carroccio A; Bascone F; Di Martino D; Bonfissuto G; Notarbartolo A
Ann Ital Med Int; 1995; 10(2):89-92. PubMed ID: 7619657
[TBL] [Abstract][Full Text] [Related]
38. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
[TBL] [Abstract][Full Text] [Related]
39. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
40. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
